Targeting Influenza A Nucleoprotein
Posted by SR in News, tags: drug discovery, influenza, virologyAlthough the recent sporadic outbreaks of influenza A virus H5N1 and of a new variant of H1N1 in 2009 were less serious than initially feared, public health responses gave an indication of the potential for pandemic influenza A to wreak havoc amongst human populations. Timely development of vaccines should help to contain future outbreaks, but effective antiviral medicines will also be needed. Circulating strains of influenza A virus with resistance to existing neuraminidase inhibitors have already been discovered, and new molecular targets would provide additional protection in the event of a fresh outbreak.

Nucleozin
The study, which is published in Nature Biotechnology, shows that the nucleoprotein is a viable drug target and could lead to the development of new treatments to control the impact of future influenza A outbreaks. Potential binding sites for nucleozin on the influenza nucleoprotein were also predicted using molecular docking models.
Related posts:
- Influenza Infection Could Lead to Neurological Complications Later in Life Neurological complications such as encephalitis have been associated with influenza outbreaks since the middle ages but links with neurodegenerative diseases...
- NS1 Protein ‘Hides’ Influenza Virus RNA The non-structural (NS1) protein of influenza A viruses plays a major role in countering host immune defence by limiting production...
- Influenza in the News Both bird and human flu have been in the news during December. Fresh outbreaks of bird flu have recently been...
- Influenza ‘Cap Snatcher’ Identified Seasonal epidemics of the influenza virus continue to kill hundreds of thousands of people annually, and the increasing incidence of...
- New Targets to Fight Flu Influenza A is a major human and animal pathogen with the ability to mutate and cross species: the recent emergence...
Related posts brought to you by Yet Another Related Posts Plugin.
This entry was posted on Friday, June 4th, 2010 at 8:30 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
















Entries (RSS)